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Welcome to 2009’s first quarter E-Brief, 
designed to inform readers about key 
global health activities at the Centers for 
Disease Control and Prevention (CDC). 
Our first issue of the year demonstrates 
how the agency has worked with non-
traditional public heath partners in the 
private sector to improve the health of 
people around the world.  Amidst the 
global economic crisis, public-private 
partnerships have become a vital way to 
leverage increasingly limited resources to 
help respond to country needs, advance 
progress on U.S. Government global 
health initiatives, and achieve the greatest 
possible health impact. 
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CDC Foundation Helps CDC Do More, Faster 
Around the World
CDC scientists battle the world’s toughest public 
health challenges, but rarely do they act alone. They rely 
on many vital alliances, including partnerships forged 
through the CDC Foundation, to achieve mutually 
beneficial goals. 
Since 1995, the CDC Foundation has helped CDC 
connect with foundations, corporations, organizations 
and individuals to build programs that improve the 
health and safety of people around the world. A private 
nonprofit organization established by Congress, the 
CDC Foundation currently helps facilitate more than 175 
active CDC programs in the United States and more than 
30 countries.
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CDC Foundation partnerships sometimes begin with 
CDC scientists who have ideas, but lack resources. At 
other times, organizations recognize that they can 
better accomplish their own public health goals by 
working through the CDC Foundation.
“For CDC, building alliances with private sector 
partners is often critical to moving important work 
forward. That’s why the CDC Foundation exists,” said 
Charles Stokes, president and CEO. “We bring CDC 
together with organizations interested in the same 
public health issues, then facilitate and implement 
meaningful programs to achieve common goals.”
For example, Cargill, an international producer and 
marketer of food, agricultural, financial and industrial 
products and services, works with the CDC Foundation 
to fight micronutrient deficiency in the developing 
world. Cargill provides funding for the Flour Fortification 
Initiative (FFI), a coalition of CDC and partners that 
works to increase the vitamin and mineral content in 
staple foods to prevent anemia and developmental 
disabilities.
CDC Foundation partners often help CDC engage 
in public health efforts that the agency does not have 
the resources to implement on its own. For example, a 
recent grant from the Bill & Melinda Gates Foundation 
will help CDC and the World Health Organization 
(WHO) strengthen disease surveillance and response in 
developing countries in Central Africa, where disease 
outbreaks and new emerging infections pose significant 
health threats. The project will help guide Central 
African health officials as they investigate, verify and 
respond to threats.
As one of a number of partners in the Bloomberg 
Initiative to Reduce Tobacco Use, the CDC Foundation 
works with experts at CDC and WHO to implement the 
Global Adult Tobacco Survey (GATS). GATS monitors 
adult tobacco use and the effectiveness of tobacco 
control measures in 16 countries that are home to 
approximately two-thirds of the world’s smokers. To 
date, the survey has been completed in Brazil and Turkey 
and will be implemented in the remaining countries 
during 2009. A new round of countries will be selected 
in 2010.  
The Central Africa surveillance and global tobacco 
survey projects are just two examples of the diverse 
activities supported by the CDC Foundation. Each 
project offers CDC greater flexibility, accountability and 
speed than might otherwise be possible.  
“An important part of the Foundation’s role in 
building partnerships is providing accountability and 
ensuring the successful implementation of programs,” 
said Stokes. “CDC Foundation staff members are directly 
involved in negotiating project details, hiring people, 
writing contracts and managing budgets. We offer our 
partners unparalleled opportunities to join with CDC to 
fight some of the world’s most complex public health 
problems.” 
Learn more about CDC Foundation partnership 
opportunities at www.cdcfoundation.org.
CDC and Rotary International: Partnering to End 
Polio
For only the second time, since smallpox was 
successfully eradicated in 1977, the world has the 
chance to eradicate a deadly virus and bring an end to 
the suffering and deaths associated with it. Today, polio 
is on the cusp of similar success.
One of the most successful public-private 
partnerships in history, the global polio eradication 
initiative was launched in 1988 by CDC, Rotary 
International, the United Nations Children’s Fund 
(UNICEF), and the World Health Organization (WHO).  In 
the 20 years since then, the number of polio cases has 
been reduced by more than 99%, from 350,000 cases per 
year to fewer than 1,700 in 2008. In 2009, the number 
of polio-endemic countries has fallen from 125 to only 
four—Afghanistan, India, Nigeria, and Pakistan.  
The CDC Foundation connects CDC with private sector partners to improve 
the health and safety of people around the world.  As a partner in the 
Bloomberg Global Initiative to Reduce Tobacco Use, CDC Foundation works 
with experts at CDC and the World Health Organization (WHO) to implement 
the Global Adult Tobacco Survey (GATS) in 16 countries that account for 
approximately two-thirds of the world’s smokers, including Bangladesh.
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Through a combination of fund-raising, advocacy, and 
volunteerism, Rotary, the private partner among the 
founding organizations of the partnership, has played a 
critical role in the extraordinary progress towards polio 
eradication. Rotary is the world’s largest humanitarian 
service organization, with 1.2 million business and 
professional leaders in a global network of 33,000 clubs. 
Rotary members have contributed nearly $800 million 
for purchase of polio vaccine, operational costs for 
large-scale vaccination campaigns, medical personnel, 
surveillance, and lab equipment. Rotary has also helped 
influence donor governments to contribute more than 
$3 billion to the initiative. The United States is the largest 
government donor, providing more than $1.5 billion.
In January 2009, the Bill & Melinda Gates Foundation 
awarded to Rotary a $255 million challenge grant to fight 
polio, which Rotary will match with $100 million raised by 
its members over the next three years. Announcing the 
award, Bill Gates said, “Rotary in particular has inspired 
my own personal commitment to get deeply involved in 
achieving eradication.”
CDC and WHO are lead technical partners in the 
initiative. CDC assigns public health experts to WHO and 
UNICEF regional and country offices, where they hold 
leadership positions in polio and immunization programs. 
CDC also provides funds for oral polio vaccine required 
for large-scale vaccination campaigns, and serves as the 
“viral detective” among the partners—CDC scientists use 
their expertise to identify the strain of poliovirus involved 
in a case and pinpoint its exact geographical origin, 
providing essential information about actions to take to 
stop the virus’ spread.   
Rotary International complements CDC and WHO 
technical expertise through its huge network of 
volunteers working hand-in-hand with CDC and WHO. 
With the motto “Service Above Self,” more than 1 million 
Rotary International members worldwide have rolled up 
their sleeves as volunteers in the fight against polio. The 
volunteers pay their own travel expenses on such trips; 
they return with first-hand experience of the program 
and share their stories with their home Rotary clubs. In 
January 2009, a marketing and management consultant 
from south Florida led a team of 42 Rotary volunteers to 
India to help vaccinate children against polio—her third 
such trip.  An insurance agent in Seattle has led Rotary 
volunteer teams to his native Ethiopia to immunize 
children with the oral polio vaccine.
Rotary and CDC are very much partners on the ground, 
collaborating closely on several specific projects to 
support the initiative.  
For example, during the first campaigns against polio 
in war-torn southern Sudan, Rotary started an emergency 
response initiative that allowed funds to be raised rapidly 
in times of outbreaks or other program emergencies. CDC 
has helped advise Rotary about public health priorities 
and technical issues for the use of these funds. Another 
example is the initiation by CDC staff, in cooperation with 
the CDC Foundation, of the Polio Eradication Heroes Fund 
to provide recognition and a stipend to surviving family 
members when volunteers in polio-endemic countries 
were killed while conducting eradication activities. Rotary 
is the single largest donor to this fund and advises the 
CDC Foundation about deserving volunteers who should 
be considered for this award. Through 2008, 74 awards 
totaling $73,800 have been given to surviving families 
through the Heroes Fund.
“The impact of the CDC-Rotary partnership has been 
demonstrated in hundreds of ways—from supporting 
short-term technical experts to implement the Global 
Polio Eradication Initiative in dozens of countries to 
recognizing those who have been injured or lost their 
lives carrying out polio immunization activities,” says 
Carol Pandak, manager of the PolioPlus program at 
Rotary International.
While work remains until polio is completely 
eradicated, the public-private partnership to end polio 
has directly affected the lives of many in developing 
countries.  The cumulative efforts of all the partners 
have meant that more than 250,000 deaths have 
been prevented and 5 million children are walking 
today who otherwise would have been paralyzed.     
Since 1988, when CDC joined forces with the World Health Organization, 
UNICEF, and Rotary International, the number of cases around the world 
has dropped dramatically. All four partners were recently inducted into the 
Polio Hall of Fame. Shown here (Left to Right) are Carol Pandak, PolioPlus 
program manager, Rotary International; Werner Obermeyer, deputy director, 
WHO UN Headquarters; Anne Schuchat, Interim Deputy Director for Science 
and Program, CDC; and Ahmed Magan, senior health advisor & chief of 
Immunization, UNICEF.
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Innovative New Technology Shows Promise in 
Assessing Populations Affected by Natural, Other 
Disasters
 It’s a bird, It’s a plane. It’s a kite. It’s a blimp. It’s a   
helicopter. 
When you take away the bird you have four examples 
of flying objects that have all been used to test an 
exciting new surveillance platform in the works at CDC.
Since 2006, CDC has worked with the Georgia Institute 
of Technology to develop a low-cost, high-resolution 
device that produces images for population assessment 
in disasters. The idea is to develop a convenient and easy 
way to get near real-time aerial photos during complex 
humanitarian emergencies. 
The Modular Photographic Observational Device, or 
“ModPod,” idea grew out of a need to conduct rapid 
assessments after disasters so that responders can plan 
an effective response.  
“You could apply the surveillance platform to 
just about anything,” says CDC’s Steve Bullard, an 
environmental health scientist. “In addition to refugee 
data, it can be used to rapidly collect images of chemical 
spills, terrorist events, or other events for which photos of 
what has happened on the ground are needed.”
Following a natural or man-made disaster, hundreds 
of thousands of people can be dislocated. For example, 
when the category 3 cyclone, Nargis, made landfall in 
Burma it caused more than 85,000 deaths and displaced 
more than 800,000 people.  When events like this occur, 
public health responders need a good estimate of the 
population size in the affected area to plan rations, 
shelter, water, and the provision of healthcare services.  
The ModPod could have been used to photograph 
the affected area to determine the magnitude of the 
devastation and assist in establishing the needs of the 
people. Population estimates are also essential when 
conducting surveys and outbreak investigations. 
Initially, the CDC team that developed the ModPod 
tried using satellite imagery to gather data on refugee 
camps, but quickly ran into obstacles. Satellite imagery is 
expensive. Coverage over remote areas can be infrequent. 
Clouds limit visibility. And, a significant time lag often 
occurs between the collection of a satellite image and 
its release to non-US government partners and disaster 
responders. CDC recognized that these challenges could 
largely be overcome by using an inexpensive aerial 
camera and a system to link the resulting photos.
Because the United Nations frequently flies helicopters 
in areas affected by complex humanitarian emergencies, 
CDC decided to build a modular system that could be 
suspended from helicopter skids. This modular system 
can be configured in different ways, with different lenses 
and capabilities, depending on available resources. For 
example, an “infrared” lens could be added to detect heat 
sources, or a low-cost optical lens can be used to capture 
imagery. The team approached several universities to 
discuss collaboration and ultimately developed a close 
partnership with the Georgia Tech Research Institute, 
which took the lead on technical design, wiring, and 
system integration.
Using an inexpensive camera and a housing unit 
typically used to carry alpine ski equipment, the ModPod 
relies on a geographic positioning system (GPS) to “tell” 
the camera when it is flying over an area of interest. Once 
inside that zone, the camera begins taking overlapping 
pictures. The camera stops when the ModPod leaves 
the area. When the helicopter lands, the pictures are 
downloaded onto a laptop. A composite image of the 
entire zone is created using commercial software. The 
system even allows users to re-create the ModPod flight 
path in GoogleEarth. Using the resulting mosaic image, 
the team is now working to refine methods of conducting 
rapid population estimates. 
In August 2008, the ModPod was flown over 
Oglethorpe University, Atlanta, GA, in one of many 
ongoing system tests. The ModPod successfully took 
pictures of students in the stadium, cars, trees, and even 
backpacks on an open field. The camera resolution is not 
sufficient to capture individual faces.
CDC’s Steve Bullard tests an early version of the ModPod on the CDC remote-
controlled airship. The photo was taken during the 3-day Georgia Breast 
Cancer Walk in 2006.
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What’s next? The group continues to test and improve 
the system so that it can be ready for use in the event of 
a public health emergency.  For this new technology, the 
sky’s the limit!
Partnership with Merck and GlaxoSmithKline 
Gets Essential Drugs to People at Risk of Tropical 
Diseases
In a quiet, dusty village in Togo—a resource-poor 
country of some 5 million people in west Africa—lies the 
seed of what for many is only a dream: a chance to break 
the cruel cycle of poverty and disease. 
That seed is a model program that successfully 
integrates public health interventions to control Guinea 
worm disease, malaria, and a group of neglected tropical 
diseases (NTDs):  lymphatic filariasis (elephantiasis); 
trachoma (eye infection); soil-transmitted helminths 
(hookworm, roundworm, whipworm); and schistosomiasis 
(snail fever). These NTDs cause substantial disability or 
poor health for hundreds of millions of people around 
the world. In addition to causing physical and emotional 
suffering, these debilitating and disfiguring diseases 
hamper worker productivity, keep children out of school, 
and prevent families and communities from thriving.
The Togo program is simple and community-driven. 
Villagers are given three drugs once a year to prevent 
disease transmission. At the annual visit, pregnant 
women with young children are encouraged to buy bed 
nets at low cost for prevention of malaria and other 
insect-carried diseases such as lymphatic filariasis. The 
women are also reminded to report any case of Guinea 
worm disease, an NTD that has been virtually eliminated 
in Togo. 
What makes this program a success? It is effective, 
inexpensive, and sustainable. 
The low cost of the program ($0.22 per person during 
the first year and $0.10 per person each year after) is 
possible because of a partnership between CDC, Merck, 
and GlaxoSmithKline to eliminate NTDs using a strategy 
of mass drug administration. 
Today, because of the generosity of Merck and 
GlaxoSmithKline, who are providing free drugs “for as 
long as needed” and funding for coalition building, 
increasing numbers of governmental and non-
governmental organizations are joining philanthropic 
groups such as the Gates Foundation to provide a low-
cost, rapid impact package of essential NTD drugs to 
the bottom billion of the poorest people—what some 
public health experts consider “the best bargain in public 
health.” 
CDC has long played a critical role in the eradication, 
elimination, or control of these diseases through its 
technical expertise in epidemiology, entomology, 
immunology, and molecular diagnostics. CDC scientists 
have contributed to the mapping of these diseases, 
studied the physical damage they cause, studied ways 
to prevent them and, in the case of lymphatic filariasis, 
studied ways to treat its long-term disabling and 
disfiguring effects.   CDC also contributes its expertise in 
monitoring and evaluating the interventions.
Dr. Els Mathieu, a CDC scientist who studies NTDs, 
has spent months in Togo with the Ministry of Health 
training, advising, monitoring, and evaluating the 
concept of integrated disease management. With tools 
now available to eliminate and control these diseases, 
she helped shepherd the program into success. She knew 
it could work. “The solutions are here. The partners are on 
board.” 
In fact, evaluation of the model program of integrated 
interventions has shown that 80% of the population in 
the targeted districts has received drug coverage for 
four diseases: onchocerciasis, lymphatic filariasis, soil-
transmitted helminths, and schistosomiasis.  In addition, 
evidence indicates that Togo may be the first African 
country to interrupt transmission of lymphatic filariasis.
After seeing the initial success, “the Togolese are 
anxious to scale up the program so the entire country can 
benefit,” Mathieu adds. 
It is hoped the program will become a model for the 
entire country of Togo and eventually all of West Africa. 
Dr. Els Mathieu, a CDC scientist, works with community members on integrated 
disease management in Togo.
Public-Private Partnership Strengthens 
Laboratory Systems in Fight against AIDS and 
Tuberculosis  
With more than 33 million people in the world living 
with HIV and 2.7 million new HIV infections each year 
(UNAIDS 2008 Report on the Global AIDS Epidemic), 
prevention and control efforts can seem daunting even 
in the best of settings. Yet weaknesses in the health care 
systems in most countries supported by the President’s 
Emergency Plan for AIDS Relief (PEPFAR) are enormous 
and no single entity—governmental, non-governmental 
organization, or industry—can meet these challenges 
alone.  
A partnership between PEPFAR and Becton, Dickinson 
and Company (BD), a leading global medical technology 
company with laboratory expertise, is maximizing limited 
resources and helping to build robust, sustainable 
laboratory facilities. 
In the fight against HIV/AIDS in Africa, a strong 
laboratory system is critical for proper prevention, 
treatment, and care. Laboratory data are essential to 
accurately assess the status of patients’ health, make 
accurate diagnoses, plan a course of treatment, and 
subsequently monitor the effects of treatment. Health care 
workers must be able to trust that laboratory test results 
are accurate, reliable and timely.  
In October 2007, PEPFAR—through CDC and BD—
launched a five-year public-private partnership, the first of 
its kind, to improve overall laboratory systems and services 
in African countries severely affected by HIV/AIDS and 
tuberculosis (TB).
With up to $18 million in funding, the partnership is 
being initiated in eight African countries: Côte d’Ivoire, 
Ethiopia, Kenya, Malawi, Mozambique, South Africa, 
Tanzania, and Uganda. The strategy includes three key 
components: 
     laboratory-strengthening programs built on          
 National Laboratory Strategic Plans tailored to   
     meet specific country needs; 
 fellowship programs for BD associates to share   
 their expertise with implementing partners, and 
 short-term technical assistance by both BD and   
 PEPFAR partners to provide laboratory training at  
 multiple levels within a country.  
The collaboration is greatly leveraging the level of 
assistance offered to all PEPFAR-supported countries 
in Africa, and is preparing more health care workers to 
provide quality HIV testing and improved TB diagnoses. 
In Uganda, for example, CDC and BD are using Global 
Positioning System/Global Information System (GPS/GIS) 
technology to map multiple laboratory sites with the goal 
of developing a transportation network and monitoring 
specific improvements in the identified laboratories.  
According to John Nkengasong, a CDC scientist and co-
chair of the PEPFAR Laboratory Technical Working group, 
“The PEPFAR-BD partnership has taken the lead in Uganda 
to strengthen laboratory systems by developing quality 
management and specimen transport referral systems. 
These efforts will go a long way to improve the care people 
receive, and ultimately their health.”
The collaboration with BD is one more example of how 
public-private partnerships effectively link resources and 
technology in the private sector with scientific expertise 
in the public health community. These partnerships 
are critical for scaling up what works, building capacity 
of governments and local organizations, and creating 
sustainable programs – all essential steps needed to help 
move the AIDS response forward and enable communities 
and countries to change this epidemic’s deadly course. 
Participants from Nigeria and Ethiopia watch as specimens are logged in before 
processing for TB cultures during the lab strengthening training.
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Update: Child Violence Survey in
Swaziland Spurs Government to
Establish the Sexual Offenses 
Unit
The third quarter 2007 Global 
Health E-Brief featured an article 
on a United Nations Children’s 
Fund (UNICEF) and CDC survey to 
determine the rates of violence 
against young people in Swazi-
land. The results of this survey 
revealed alarming rates of vio-
lence against children, including 
one in three females between the 
ages of 13 and 24 suffering from 
some form of sexual violence dur-
ing childhood. As a result of this 
survey a new Sexual Offenses Unit 
for children and young people has 
been established. The launch of 
this unit is the first step towards 
developing comprehensive care 
for victims of sexual exploitation, 
violence, and abuse in Swaziland. 
For more information please visit: 
http://www.unicef.org/protection/
swaziland_46978.html
Update: Cholera Outbreak in 
Zimbabwe
As of March 12, 2009, the World 
Health Organization (WHO) Office 
in Zimbabwe and the Ministry of 
Health report that there are 89,930 
suspected cases of cholera with 
4,049 deaths.  This is an increase 
of 56,351 cases and 2,378 deaths 
since the report in the last Global 
Health E-Brief (Fourth Quarter, 
2008).  CDC deployed a health 
communicator in December 2008 
to assist with   informational/edu-
cational messages, and in March 
2009 is deploying a medical epide-
miologist based in Kenya, as part 
of a WHO Global Outbreak and 
Alert Response Network (GOARN) 
team, to provide further technical 
assistance in the outbreak. CDC 
remains in contact with its staff in 
the region in Mozambique, South 
Africa, Zambia, and Zimbabwe, and 
is working with WHO and other 
global health partners to further 
monitor this situation and assist 
when possible.    
“A Lion in Our Village - The 
Unconscionable Tragedy of 
Cholera in Africa” 
“A Lion in Our Village - The Un-
conscionable Tragedy of Cholera 
in Africa”, published in the March 
12th edition of the New England 
Journal of Medicine, details the 
burden of cholera in Zimbabwe 
and other surrounding African 
countries in the past year. Rarely 
seen in the United States, cholera 
used to be endemic in South Asia 
before oral rehydration therapy 
was introduced and reduced the 
fatality rate from 30 percent to less 
than 1 percent. After a century-
long absence, a cholera epidemic 
in Latin America in the 1990s was 
met with swift investment in drink-
ing water, sanitation and health 
care.
The sanitation and treatment revo-
lutions have not made the same 
progress in Africa, where there 
have been more than 92,000 cases 
and 4,000 deaths due to cholera 
since November 2008 in Zimba-
bwe alone. The epidemic shows no 
signs of slowing and has spread to 
other countries.
Dr. Eric Mintz, a CDC scientist with 
expertise in diarrheal diseases, and 
Dr. Richard L. Guerrant, Director 
of the Center for Global Health at 
the University of Virginia, School 
of Medicine, point to a lack of safe 
drinking water, sanitation, and 
hygiene facilities as the underlying 
causes of spread of the epidemic, 
and inadequate access to basic 
health care services and supplies 
as the cause of the high mortal-
ity rate. A waterborne disease, 
cholera is the result of inadequate 
treatment of sewage or drinking 
water.  The article can be accessed     
at http://content.nejm.org/cgi/
content/full/360/11/1060
Rabies Partnership Expands 
Education Efforts with Help of 
Google
Since 2006, CDC has partnered 
with the Alliance for Rabies 
Control (ARC) to help promote 
rabies education worldwide. As 
part of the collaboration, CDC has 
assisted with the development of 
public health education materials 
for rabies education campaigns in 
Latin America, Africa, and Asia. The 
ARC recently received a grant from 
Google to expand its marketing 
campaign around human rabies 
prevention and animal rabies 
control, and in particular, its 
efforts focused around World 
Rabies Day which occurs this 
year on September 28. Currently, 
it is estimated the Alliance is 
communicating prevention 
messages into 190 countries. For 
information about ARC, please visit 
http://www.rabiescontrol.net/
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